Financial Gravity Asset Management’s AbbVie ABBV Stock Holding History

Financial Gravity Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.1K	Buy	336 +20	+6%	+$4.44K	0.01%	257
2025 Q4	$72.2K	Buy	316 +66	+26%	+$15K	0.01%	217
2025 Q3	$57.9K	Buy	+250	New	+$50.9K	0.01%	280
2025 Q1	$59.3K	Buy	+283	New	+$55K	0.01%	282
2024 Q2	$38.9K	Hold	227	–	–	0.01%	298
2024 Q1	$35.2K	Sell	227 -1	-0.4%	-$172	0.01%	302
2023 Q4	$35.3K	Buy	+228	New	+$33.2K	0.01%	303
2021 Q3	$108K	Hold	2	–	–	0.05%	339
2021 Q2	$113K	Buy	+2	New	+$225	0.04%	321
2020 Q4	$0	Buy	+3	New	+$288	﹤0.01%	471
2019 Q4	$121K	Sell	357 -50	-12%	-$4.15K	0.08%	247
2019 Q3	$31K	Sell	407 -96	-19%	-$6.58K	0.03%	370
2019 Q2	$37K	Buy	503 +228	+83%	+$17.9K	0.03%	380
2019 Q1	$22K	Buy	+275	New	+$22.5K	0.02%	425
2018 Q3	$365K	Buy	4,490 +427	+11%	+$40.5K	0.38%	41
2018 Q2	$389K	Buy	4,063 +114	+3%	+$11.1K	0.36%	38
2018 Q1	$396K	Buy	+3,949	New	+$434K	0.41%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Financial Gravity Asset Management's ABBV Position: Q1 2026 in Review

Financial Gravity Asset Management increased its AbbVie (ABBV) stake by 6.3% in Q1 2026, buying an estimated $4.44K and bringing the position to 336 shares worth $73.1K. The position accounts for 0.01% of the portfolio, ranked #257.

Financial Gravity Asset Management first reported a position in ABBV in Q1 2018 and has held it in 17 quarters since. The position peaked at $396K in Q1 2018. 4,104 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Financial Gravity Asset Management held 336 shares of AbbVie worth $73.1K as of Q1 2026.
Financial Gravity Asset Management bought 20 AbbVie shares in Q1 2026, an estimated $4.44K.
AbbVie made up 0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #257 holding.
Financial Gravity Asset Management first reported a position in AbbVie in Q1 2018 and has held it in 17 quarters since.
Financial Gravity Asset Management's AbbVie position peaked at $396K in Q1 2018.
4,104 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.